Abstract
Research Overview
Frost & Sullivan's Medical Devices Financial Benchmarking & Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the North American Cardiovascular Devices Market: cardiac rhythm management, interventional cardiology, and cardiac surgery.
Increased Consolidation and Improved Prospects for Venture Capital Investors
The North American Cardiovascular Devices Industry is characterized by a relatively fewer number of participants that are on an aggressive acquisition spree. With the acquisition of Guidant by Boston Scientific, the space is consolidating further. Moreover, smaller companies that develop technologies catering to an unmet need, or that convert a surgery from an in-patient to an out-patient setting, have historically been the takeover targets by larger companies. Against such backdrop, this study aims to address issues such as: the impact of consolidation on venture capital investments in the industry, the effect of the consolidation on the exit market for venture capitalists, the IPO market as an exit strategy for venture capital investors, and the segments that demonstrate significant growth potential and are attracting increased interest.
Rise in Number of Out-Patient Surgeries Providing Additional Investment Opportunities
There is an increasing preference in the market for minimally invasive surgeries amongst patients as well as doctors. These surgeries are associated with lesser trauma, shorter recovery time, and lesser post operative pain. Cardiologists also stand to gain from this trend, as more surgeries can be performed at a given time.Thus, any technology that could convert a surgery from an in-patient to an outpatient setting is considered to be a good investment and is welcomed by the market.
Table of Contents
1 EXECUTIVE SUMMARY
2 INTRODUCTION AND METHODOLOGY
3 INVESTMENT ANALYSIS AND GROWTH OPPORTUNITIES
- Market Overview
- Introduction
- Cardiac Rhythm Management
- Interventional Cardiology
- Cardiac Surgery
- Industry Economics
- Investment Analysis and Growth Opportunity
- Investment Themes
- Value Chain Analysis
- Sector Scorecard
- Company Investment Opportunity Scorecard
- Frost & Sullivan Cardiovascular Devices Growth Monitor
4 FINANCIAL BENCHMARKING AND VALUATION
- Frost & Sullivan Cardiovascular Devices Universe
- Ratio Analysis
- Year-over-Year Sales Growth
- Operating Margin
- Selling General and Administrative (SGA) Expenses to Sales
- Research and Development (R&D) to Sales
- Revenues per Employee
- Return on Average Assets vs. Return on Average Equity
- Capital Expenditure (Capex) to Sales
- Current Ratio
- Receivable and Payable Days
- Inventory Turnover Ratio
- Working Capital Ratio
- Asset Turnover Ratio
- Common Size Analysis
- Fixed Cost Analysis
- Valuations
- Historical Valuation based on Sales and Profitability
- EV / LTM Sales Trend
- Year to Date Stock Performance
- Frost & Sullivan Cardiovascular Devices Index
- Industry Growth Outlook
- EPS Impact Analysis
- Private Equity and Venture Capital Activity
- Mergers and Acquisitions
